Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

42.06%

Threshold

Crossed upwards

Timeline

Published

09.12.2015

Transaction

01.12.2015

Voting rights breakdown

Voting rights acquired42.06%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 6

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBFC800063

Beneficial owner

Venture Incubator AG

Declared address

Venture Incubator AG, 6302 Zug

Each investor has undertaken severally, not jointly, to exchange its shares in Kuros against shares in Cytos as outlined in the combination agreement between Cytos and Kuros dated December 1, 2015, and subject to the terms and conditions set forth therein. At the closing of the transaction, Cytos is expected to issue between 353,006,886 new registered shares (assuming 90% of Kuros shares are exchanged for new Cytos shares) and 392,229,873 new registered shares (assuming 100% of Kuros shares are exchanged for new Cytos shares). Accordingly, the number of shares/voting rights pursuant to the entry in the commercial register will be between 461,022,162 and 500,245,149 at the time the investors will actually become shareholders in Cytos. It is expected that the investors will hold between 9.08% and 9.86% total equity securities and purchase positions post closing. VI Partners AG is a shareholder and the management company of Venture Incubator AG, a multi-investor investment company. Messrs. Nicod, Braguglia, Gutenberg, Kaltofen and Mächler are shareholders of VI Partners AG.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open